Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03125824 · ClinicalTrials.gov registry record · NA
Soliton Planar Acoustic Wave Device System for Dermal Tattoo Clearing Human Trial Protocol
A NA study of Tattooing, sponsored by Soliton.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT03125824 is a NA study of Tattooing that has completed, run by Soliton. The registered enrollment target is 20 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03125824, a NA study of Tattooing, has completed, sponsored by Soliton.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
To further evaluate accelerated fading resulting from additional treatment sessions of Soliton AWD as accessory to laser in tattoo reduction treatment.
Conditions Studied
Interventions
- DEVICE Soliton Acoustic Wave Device
Study Locations (1)
Massachusetts
- SkinCare Physicians - Chestnut Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2017-02-13 |
| Est. Completion | 2018-09-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03125824
The ClinicalTrials.gov registry entry for NCT03125824 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Soliton, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Tattooing appearing as the primary indexed condition, and to 1 intervention - of which Soliton Acoustic Wave Device is the first listed.
NCT03125824 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT03125824 about?
NCT03125824 is a clinical study titled "Soliton Planar Acoustic Wave Device System for Dermal Tattoo Clearing Human Trial Protocol". To further evaluate accelerated fading resulting from additional treatment sessions of Soliton AWD as accessory to laser in tattoo reduction treatment.
What is the current status of trial NCT03125824?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2017-02-13. Estimated completion is 2018-09-25.
What conditions does trial NCT03125824 study?
This clinical trial studies the following conditions: Tattooing.
What interventions are being tested in trial NCT03125824?
The interventions under investigation include: Soliton Acoustic Wave Device (DEVICE).
Who is sponsoring clinical trial NCT03125824?
This trial is sponsored by Soliton, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03125824 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.